Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide

Biomedicine and Pharmacotherapy

Volumn 65, Issue 5, 2011, Pages 319-321

  Colovic M ^a,b   Suvajdzic N ^a,b   Jankovic G ^a,b   Tomin, D ^a,b   Colovic N ^a,b   Fekete, M Denčić ^b   Palibrk, V ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Acute myeloid leukemia; Fludarabine; Therapy related

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RISK; CASE REPORT; CHROMOSOME 5; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; KARYOTYPE; LATENT PERIOD; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 5; COHORT STUDIES; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC; VIDARABINE;

EID: 79960957270     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.006     Document Type: Article

References (23)

1. Yamauchi T., Nowak B.J., Keating M.J., Plunkett W. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Can Res 2001, 7:3580-3589.
2. Tam C.S., Seymour J.F., Prince H.M., et al. Treatment-related myelodysplasia following fludarabine combination chemotherapy. Haematologica 2006, 91:1546-1550.
3. Morrison V.A., Rai K.R., Peterson B.L., et al. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil. Results of an intergroup study, cancer and leukemia group B9011. J Clin Oncol 2002, 20:3878-3884.
4. Vardiman J.W., Arber D.A., Brunning R.D., et al. Therapy-related myeloid neoplasms. WHO Classification of tumours of haematopoietic and lymphoid tissues 2008, 127-129. International Agency for Research on Cancer, Lyon. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
5. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985, 103:620-625.
6. Novak A., Kruškić M., Ludoški M., Jurukovski V. Rapid method for obtaining high quality chromosome banding in the study of hemopoietic neoplasia. Cancer Genet Cytogenet 1994, 74:109-114.
7. ISCN. An international system for human cytogenetic nomenclature. Shaffer LG, Slovak ML, Campbell LJ, editors. Basel: S. Charger; 2009.
8. Cheson D.B., Vena A.D., Barrett J., Freidlin B. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphocytic leukemias. J Clin Oncol 1999, 17:2454-2460.
9. Keating M.J., O' Brien S., Lerner S., et al. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998, 92:1165-1171.
10. Leporrier M., Chevret S., Cazin B., et al. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and chronic lymphocytic leukemia patients. Blood 2001, 98:2319-2325.
11. Johnson S., Smith A.G., Loffler H., et al. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicyn, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia patients. The French Cooperative Group on CLL. Lancet 1996, 347:1432-1438.
12. Tam C.S., O' Brien S., Wierda W., et al. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood 2008, 112:975-980.
13. McLaughlin P., Estey E., Glassman A., et al. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood 2005, 105:4573-4575.
14. Bowcock S.J., Rassam S.M., Lim Z., Ward S.M., Ryali M.M., Mufti G.J. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders. Br J Haematol 2006, 134:242-243.
15. Carney D.A., Seymour J.F. Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?. Leuk Lymphoma 2010, 24:2056-2062.
16. Niparuck P., Kanoksil W., Chuncharunes S., et al. Therapy-related MDS/AML following fludarabine therapy for NHL and CLL in Thai patients. Leuk Lymphoma 2010, 51:2120-2125.
17. Carney D.A., Westerman D.A., Tam C.S., et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination therapy. Leukemia 2010, 12:2056-2062.
18. Milligan D.W., Kochethu G., Dearden C., Matutes E., McConkey C., Catowsky D. High incidence of myelodysplasia and secondary leukemia in the UK Medical Research Council pilot of autografting in chronic lymphocytic leukaemia. Br J Haematol 2006, 133:173-175.
19. Smith S.M., Le Beau M.M., Huo D., et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia. The University of Chicago series. Blood 2003, 102:43-52.
20. Travis L.B., Curtis R.E., Hankey B.F., Fraumeni J.F. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992, 84:1422-1427.
21. Andre M., Mounier N., Leleu X., et al. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients. Blood 2004, 103:1222-1228.
22. Grimwade D., Hills R.K., Moorman A.V., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010, 116:354-365.
23. Lam C.C., Ma E.S., Kwong Y.L. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. Am J Hematol 2005, 79:288-290.